Dendritic cells determine immune outcomes largely through how they capture and process antigens, and glycan composition on those antigens is a decisive factor. Ralph Steinman of Rockefeller University established the central role of dendritic cells in antigen presentation, and subsequent work has shown that sugar motifs on proteins and particles tune which dendritic cell receptors bind them, how strongly they bind, and the intracellular routing that follows. This receptor-level selectivity underlies differences in immunity versus tolerance, and it is leveraged by pathogens and vaccine designers alike.
Receptor specificity and glycan motifs
C-type lectin receptors on dendritic cells recognize distinct carbohydrate patterns. DC-SIGN binds high-mannose and certain fucosylated structures, a specificity characterized by Teunis Geijtenbeek of Academic Medical Center Amsterdam and colleagues and exploited by HIV envelope glycoprotein gp120 to enhance capture. The mannose receptor and other lectins likewise prefer terminal mannose or GlcNAc residues, concentrating mannose-rich antigens on the dendritic cell surface. Conversely, Siglecs detect sialylated glycans and often transmit inhibitory signals; Ajit Varki of University of California San Diego has documented how sialic acid patterns modulate immune recognition. Subtle differences in branching, linkage type, and density change receptor engagement from weak, transient contacts to high-avidity binding that alters uptake efficiency.
Intracellular routing and immune consequences
Which receptor mediates uptake influences antigen fate. Some lectin-mediated pathways favor endolysosomal processing and CD4 T cell priming, while targeting receptors such as DEC-205 can route antigens into pathways that enhance cross-presentation on MHC class I. Work on receptor-targeted antigen delivery by Michel Nussenzweig of Rockefeller University and others shows that directing antigens to specific dendritic cell receptors increases cytotoxic T cell responses, a principle used in vaccine design. Pathogens exploit these routes: HIV binding to DC-SIGN can promote viral preservation and transmission rather than degradation, illustrating a pathological consequence of glycan-receptor interactions.
Human and ecological nuances matter because glycan repertoires vary between tissues and species. Humans lack certain sialic acid forms present in other mammals, a point emphasized by Ajit Varki, and tissue-specific glycosylation alters which dendritic cell subsets interact with an antigen. For immunotherapy and vaccine development, glycoengineering to add or remove mannose, fucose, or sialic acid can therefore steer dendritic cell uptake and the resulting immune program. Understanding precise glycan–receptor pairs remains essential to predictably manipulate immune responses across human populations and ecological contexts.